Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results.

Slides:

Advertisements

Similar presentations

Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.

Advertisements

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Management of severe anemia secondary to menorrhagia in a Jehovah's Witness: a case report and treatment algorithm Griselda Gutierrez, MD, FACOG, Joy.

Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation.

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial Bruce.

Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal.

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST) Kirsten E. Fleischmann,

Downstream coronary effects of drug-eluting stents

Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: Results.

Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy.

Colloquium on Therapy of Right Heart Failure

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve.

Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator.

Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided.

A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement

Force- and relaxation-frequency relations in patients with diastolic heart failure Takashi Yamanaka, MD, Katsuya Onishi, MD, FACC, Masaki Tanabe, MD,

A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial.

The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics Cheryl Bushnell,

Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia.

CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy.

Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi- intervention in type 2 diabetes: The randomized controlled Asker.

Rationale and design of the FreezeAF trial: A randomized controlled noninferiority trial comparing isolation of the pulmonary veins with the cryoballoon.

Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population Richard K. Cheng, MD, MS,

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study.

Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation Hany S. Abed, BPharm, MBBS, PhD,

Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.

Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention.

NT–probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non–ST-elevation acute coronary syndromes José.

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and.

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization:

Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation Anh L. Bui, MD, Maria.

Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: An open-label, blinded end point, randomized.

National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance Judith.

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.

Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right.

Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The.

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting.

Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer Russell D. Hull, MBBS, MSc, Graham F. Pineo,

Julian A. Abrams, MD, MS, Sri Komanduri, MD, Nicholas J

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Systematic Review of the Mediterranean Diet for Long-Term Weight Loss

A Randomized Controlled Trial of a Community-based Behavioral Counseling Program Craig A. Johnston, PhD, Stephanie Rost, MS, RD, Karen Miller-Kovach,

Reduction of C-reactive protein levels through use of a multivitamin

Extreme Polyuria: At the Heart of the Answer

Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer Russell D. Hull, MBBS, MSc, Graham F. Pineo,

All-cause Mortality Associated with TNF-α Inhibitors in Rheumatoid Arthritis: A Meta- Analysis of Randomized Controlled Trials Lucile Poiroux, MD, Yannick.

Carmelo V. Venero, MD, Paul D. Thompson, MD, Antonio B. Fernandez, MD

The Recent History of Acupuncture

Loop Diuretics for Heart Failure-associated Hyponatremia

Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: A randomized controlled.

The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study Mohamed G. Atta, MD, MPH, Kesha Baptiste-Roberts,

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Rescue Bariatric Surgery for Obesity-induced Cardiomyopathy

Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?

Study Designs in Patient-Oriented Research

To Reduce Stroke with PFO Closure, Respect the Shunt

Niv Ad, MD, Lawrence M. Wei, MD

Use of diphenhydramine as an adjunctive sedative for colonoscopy in patients on chronic opioid therapy: a randomized controlled trial Salman Nusrat,

One-way Versus Two-way Text Messaging on Improving Medication Adherence: Meta- analysis of Randomized Trials David S. Wald, MD, FRCP, Shahena Butt, MSc,

Purple Urinary Bag Syndrome

Trial Quality in Nephrology: How Are We Measuring Up?

EFFECTS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS ON MORTALITY, CARDIOVASCULAR HOSPITALIZATION AND FUNCTIONAL CAPACITY IN PATIENTS WITH HEART.

Tofacitinib therapy for children with severe alopecia areata

Dialysis Research and N-of-1 Trials: Made for Each Other?

Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-β) in patients with vitiligo Rehan Khan, MSc,

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Presentation transcript:

Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results of the randomized trial Romuald Wojnicz, MD, PhD, Jolanta Nowak, MD, Bożena Szyguła-Jurkiewicz, MD, Krzysztof Wilczek, MD, Andrzej Lekston, MD, PhD, Przemysław Trzeciak, MD, Ewa Nowalany-Kozielska, MD, PhD, Marian Zembala, MD, PhD, Jan Wodniecki, MD, PhD, Lech Poloński, MD, PhD American Heart Journal Volume 152, Issue 4, Pages 713.e1-713.e7 (October 2006) DOI: 10.1016/j.ahj.2006.06.028 Copyright © 2006 Mosby, Inc. Terms and Conditions

Figure 1 Serum NT-proBNP levels at baseline and at 6 and 12 months of follow-ups. Box plots represent from 25th to 75th percentiles with median and individual data. American Heart Journal 2006 152, 713.e1-713.e7DOI: (10.1016/j.ahj.2006.06.028) Copyright © 2006 Mosby, Inc. Terms and Conditions

Figure 2 Individual patient changes in LV ejection fraction from initial study to follow-up. The asterisk indicates P, between-group comparison at 12-month follow-up. American Heart Journal 2006 152, 713.e1-713.e7DOI: (10.1016/j.ahj.2006.06.028) Copyright © 2006 Mosby, Inc. Terms and Conditions